|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||
| Deferred offering costs | ||||||||
| Prepaid expenses | ||||||||
| Current assets: | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Prepaid expenses - non-current | ||||||||
| Investments held in Trust Account | ||||||||
| Total assets | ||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT: | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Insurance loan payable | ||||||||
| Total current liabilities | ||||||||
| Promissory note - related party | ||||||||
| Deferred underwriting commissions | ||||||||
| Total liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,800,000 shares at $10.60 and $10.42 per share redemption value as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Shareholders’ Deficit: | ||||||||
| Ordinary shares, value | ||||||||
| Class A Ordinary Shares | ||||||||
| Class B Ordinary Shares | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total shareholders’ deficit | ||||||||
| Total liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
